U.S. Consumer Durables Stock News

Tango Therapeutics (TNGX) drew fresh attention after positive Phase 1/2 vopimetostat data in difficult pancreatic and lung cancer settings, coinciding with a completed US$600 million follow on equity offering. See our latest analysis for Tango Therapeutics. The recent vopimetostat data and the US$600 million follow on offering have arrived alongside strong momentum in Tango Therapeutics’ stock, with a year to date share price return of 260.13% and a 1 year total shareholder return that is...

In recent days, Atlassian has been swept up in broader swings across software stocks as changing interest rate expectations and macro headlines prompted investors to reassess the value of long-duration, high-growth technology earnings. At the same time, partner Praecipio launched a new financing program to help customers fund Atlassian-related technology projects more flexibly, highlighting ongoing demand for cloud and services investments despite market volatility. We’ll now examine how...

On 8 June 2026, Sirius XM Holdings Inc. was added to the S&P 400, S&P 1000, S&P Composite 1500 and the S&P 400 Communication Services sector indices. These index inclusions coincide with growing attention on SiriusXM’s satellite spectrum rights and operational streamlining, which together are reshaping how investors view the business. Now we’ll examine how SiriusXM’s addition to key S&P indices might influence its investment narrative, especially around spectrum monetization. Uncover the...

Archer-Daniels-Midland recently reported that stronger oilseed processing fundamentals, resilient global soybean meal demand, and favorable U.S. biofuel policy expectations have supported improving profitability across its core operations. An important angle is the growing contribution from ADM's higher-margin nutrition segment, which is increasingly shaping how investors view the balance of its traditional commodity processing and value-added ingredients businesses. Against this backdrop of...

Aehr Test Systems recently drew attention for its leading role in burn-in testing for AI chips, supported by a robust order book and record bookings reported ahead of today’s date of 17 June 2026. At the same time, the company’s elevated valuation, two years of revenue declines, gross-margin pressure, and recent insider selling highlight a tension between strong interest and more cautious fundamental signals. Next, we’ll examine how Aehr’s leadership in AI chip burn-in testing shapes the...

Blackstone has launched SablePointe Credit Strategies, a new asset-based direct lending platform. The firm has appointed James Garlick as President of SablePointe to lead the build out of this credit business. Senator Elizabeth Warren has formally questioned Blackstone over its data center ownership and ties to utilities. The inquiry focuses on transparency and environmental compliance for Blackstone's expanding AI and infrastructure assets. Blackstone, listed on the NYSE as BX, is adding a...

If you are wondering whether Medtronic stock offers reasonable value or if the recent price levels are stretching it, the current setup gives you a lot to weigh up. The shares recently closed at US$81.32, with the price down 0.8% over the last week, up 6.8% over the last month, modestly up 0.8% over three years and down 15.3% year to date and 25.2% over five years, which hints that the market has been reassessing both its potential and its risks. These mixed returns sit against a backdrop of...

If you are wondering whether Super Micro Computer stock still offers value after its big run in recent years, the next sections will break down what the current price might be implying. The stock recently closed at US$29.22 and has declined 28.1% over the past week, 5.9% over the past month and 5.6% year to date, while still sitting far above its level from three years ago. These moves come as investors continue to reassess Super Micro Computer's role in AI related infrastructure and high...

Verizon Communications (VZ) has made a series of consumer focused changes, including new Simplicity Plans that scrap activation and upgrade fees, a cashback loyalty program, and bundled mobility plus home services under unified billing. See our latest analysis for Verizon Communications. Against this backdrop of new consumer offerings, Verizon Communications shares trade at US$46.73, with a 7 day share price return of 2.08% but a 90 day share price return that is down 5.77%. Over a longer...

Nebius Group, NasdaqGS:NBIS, has completed its acquisition of Eigen AI. The deal, first announced in May, closed in June 2026 following regulatory approval. The transaction adds model optimization technology to Nebius Group's AI inference platform and creates a new engineering base in the Bay Area. Nebius Group enters this deal with recent share price momentum, with NasdaqGS:NBIS up 20.4% over the past week, 20.5% over the past month, and 194.7% year to date, based on a last close of...

Certara, Inc. ( NASDAQ:CERT ), is not the largest company out there, but it saw a significant share price rise of 35...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Investors who take an interest in PAR Technology Corporation ( NYSE:PAR ) should definitely note that the Director...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Eagle Materials Inc. recently proposed amendments to its Restated Certificate of Incorporation to declassify its Board of Directors and to grant stockholders the right to call special meetings, with both changes becoming effective upon stockholder approval and filing in Delaware. These governance moves would increase director accountability and give investors a formal mechanism to convene special meetings, potentially reshaping how the company responds to shareholder priorities. We’ll now...

Kyndryl Holdings (KD) has introduced Kyndryl AI Orchestration for Business, a new capability aimed at helping enterprises coordinate AI agents across supply chains, commerce, finance, IT and customer operations in real time. See our latest analysis for Kyndryl Holdings. The launch of Kyndryl AI Orchestration for Business comes as Kyndryl Holdings shares trade at US$12.03, with a 30 day share price return of 6.27% but a year to date share price decline of 52.80%, while the 1 year total...

Ocular Therapeutix (OCUL) continues to draw attention after recent share price moves, with the stock last closing at $8.94. Investors are evaluating its clinical pipeline, hydrogel technology and mixed short term return profile. See our latest analysis for Ocular Therapeutix. While Ocular Therapeutix shares are currently at $8.94 and have risen over the past week, the stock is still down year to date, even though the 1 year and 3 year total shareholder returns are positive. This may indicate...

Earlier this month, The Hershey Company appointed Joe Park, State Farm’s Executive Vice President and Chief Digital and Information Officer, to its Board effective June 29, 2026, with roles on the Audit and Finance and Risk Management Committees. At the same time, Hershey has been drawing investor attention for resilient demand, easing cocoa cost pressures, and earnings diversification through its growing salty snacks portfolio. We’ll now explore how Joe Park’s digital expertise and the...

At the recent Morgan Stanley US Financials Conference, Pinnacle Financial Partners detailed an accelerated hiring push, post-merger integration milestones, and balance sheet actions including senior debt issuance and the sale of municipal securities. These updates give investors a clearer view of how Pinnacle is pairing rapid expansion with efforts to preserve financial flexibility after recent portfolio and funding moves. We’ll now examine how Pinnacle’s accelerated hiring and integration...

With the US Federal Reserve under new Chairman Kevin Warsh holding rates in a 3.50%-3.75% range and markets bracing for possible future hikes, interest rate expectations are back at the center of many investment decisions. Changing policy signals and the potential loss of clear forward guidance can reward some stocks that handle this uncertainty well and expose weaknesses in others. This article highlights 3 Financial Sector Stocks from the screener that are directly exposed to this news,...

Earlier in 2026, SM Energy reported a very strong first quarter, with revenue, earnings and EBITDA all ahead of analyst expectations, while sector volatility and geopolitical tensions underscored how external forces can amplify company-specific results. The key question now is how effectively management can translate higher 2026 production guidance into sustained cash generation, given ongoing capital intensity and basin concentration risks. We’ll now examine how SM Energy’s strong...

Recent interest in Insulet (PODD) is being driven by fresh clinical data on its investigational Omnipod 6 system and fully closed-loop technology for type 2 diabetes, along with newly rolled out U.S. upgrades to Omnipod 5. See our latest analysis for Insulet. Despite the latest Omnipod 6 and Omnipod 5 headlines, Insulet’s share price has been under pressure, with the 90 day share price return down 35.9% and the 1 year total shareholder return down 51.5%. This signals weak momentum even as...

Cboe Global Markets (CBOE) recently came under pressure after traders focused on possible competition from prediction market platform Polymarket, which is seeking CFTC approval and drawing attention to how new entrants might affect exchange operators. See our latest analysis for Cboe Global Markets. The recent selloff around Cboe Global Markets, triggered by concerns over Polymarket, has pushed the share price down 27.6% over the past month and 11.9% over the last week, even though the year...

Recently, Leerink initiated coverage on Absci Corporation, emphasizing its AI-native, clinical-stage biologics pipeline, including lead candidate ABS-20 in Phase 1/2 and pipeline asset ABS-201 for alopecia and endometriosis, while MindWalk’s CEO joined Absci and a major AI compute provider on a Jones AI Day panel about AI-enabled drug discovery. Together, the supportive research coverage and Absci’s participation in a high-profile discussion on combining AI, biological context, and...